PLCL1 (NM_006226) Human Untagged Clone

SKU SC328044

PLCL1 (untagged)-Human phospholipase C-like 1 (PLCL1)

Product Data

• Type: Human Untagged Clone
• Target Symbol: PLCL1
• Synonyms: PLCE; PLCL; PLDL1; PPP1R127; PRIP
• Vector: pCMV6-Entry
• E. coli Selection: Kanamycin (25 ug/mL)
• Mammalian Cell Selection: Neomycin
• Sequence Data:
  Fully Sequenced ORF

  >SC328044 representing NM_006226.; Blue=Insert sequence Red=Cloning site Green=Tag(s); ; GCTCGTTTAGTGAACCGTCAGAATTTTGTAATACGACTCACTATAGGGCGGCCGGGAATTCGTCGACTG; GATCCGGTACCGAGGAGATCTGCCGCCGCGATCGCC; ATGGCCGAGGGCGCGGCCGGCAGGGAGGATCCGGCGCCGCCCGACGCGGCGGGGGGCGAAGACGACCCC; CGAGTGGGCCCGGATGCCGCCGGGGACTGCGTGACGGCGGCCTCTGGGGGCCGGATGAGGGACCGTCGC; AGCGGGGTCGCACTGCCAGGCGCCGCGGGGACCCCAGCGGACAGCGAGGCGGGCCTCCTGGAGGCAGCA; CGGGCGACCCCCCGGCGCAGCAGCATCATCAAGGATCCTTCAAACCAAAAATGTGGTGGAAGAAAGAAA; ACCGTGTCTTTCAGCAGCATGCCATCGGAAAAGAAAATTAGCAGTGCAAATGACTGCATCAGCTTCATG; CAAGCTGGCTGTGAGTTGAAGAAAGTCCGGCCAAATTCTCGCATTTACAACCGTTTTTTCACTCTGGAC; ACAGACCTTCAAGCTCTTCGCTGGGAACCTTCAAAGAAAGACCTCGAGAAAGCCAAGCTTGATATTTCT; GCCATAAAAGAGATCAGACTGGGGAAAAACACGGAAACATTTAGAAACAATGGCCTTGCTGACCAGATC; TGTGAGGACTGTGCCTTTTCCATACTCCACGGGGAAAACTATGAGTCTCTGGACCTAGTTGCCAATTCA; GCAGATGTGGCAAACATCTGGGTGTCTGGGTTACGGTACCTGGTTTCTCGAAGTAAGCAGCCTCTTGAT; TTTATGGAGGGCAACCAGAACACACCACGGTTCATGTGGTTGAAAACAGTGTTTGAAGCAGCAGATGTT; GATGGGAATGGGATTATGTTGGAAGACACCTCTGTAGAGTTAATAAAACAACTCAACCCTACTCTGAAG; GAAGCCAAGATCAGGTTAAAGTTTAAAGAAATCCAGAAGAGCAAGGAAAAACTAACCACCCGCGTGACC; GAAGAGGAATTTTGTGAAGCTTTTTGTGAACTTTGCACCAGGCCAGAAGTGTATTTCTTACTTGTACAG; ATATCTAAAAACAAAGAATATTTGGATGCCAATGATCTCATGCTCTTTTTAGAAGCTGAGCAAGGAGTC; ACCCATATCACCGAGGATATATGCTTAGACATCATAAGGAGATACGAACTTTCTGAAGAGGGACGTCAA; AAAGGGTTTCTTGCAATTGATGGCTTTACCCAGTATTTATTGTCATCAGAATGTGACATTTTTGATCCT; GAGCAAAAGAAGGTTGCCCAAGATATGACCCAGCCATTATCTCACTACTATATCAATGCCTCTCATAAC; ACCTATCTAATAGAAGACCAGTTCAGGGGGCCAGCTGACATCAATGGGTACATTAGAGCTTTGAAAATG; GGCTGTCGAAGCGTTGAACTCGATGTAAGTGATGGTTCAGATAATGAACCAATCCTTTGTAATCGAAAT; AACATGACAACCCATGTTTCCTTTCGAAGTGTCATAGAGGTAATAAATAAATTTGCCTTTGTTGCTTCT; GAATACCCACTCATTCTTTGCTTGGGAAATCACTGCTCCTTGCCGCAGCAGAAGGTAATGGCTCAACAG; ATGAAAAAGGTCTTTGGCAATAAACTCTATACTGAAGCACCTTTGCCCTCAGAATCCTACCTCCCATCA; CCAGAAAAATTAAAAAGAATGATCATTGTGAAAGGAAAGAAGTTGCCTTCTGATCCAGATGTGTTAGAA; GGAGAAGTAACAGATGAAGATGAAGAAGCTGAAATGTCTCGAAGGATGTCGGTAGATTACAATGGTGAG; CAGAAGCAAATCCGACTCTGTAGGGAGCTCTCTGATTTGGTGTCTATTTGTAAATCTGTTCAATACAGG; GATTTTGAACTATCTATGAAAAGCCAAAACTATTGGGAAATGTGTTCATTTAGTGAAACAGAGGCCAGC; CGCATTGCAAATGAGTACCCAGAGGATTTTGTTAATTATAATAAGAAGTTCTTATCAAGAATCTATCCA; AGTGCCATGAGGATCGATTCCAGTAACTTGAATCCACAGGACTTTTGGAATTGTGGCTGTCAGATTGTA; GCAATGAATTTTCAGACTCCGGGTCCAATGATGGACCTTCACACGGGCTGGTTTCTTCAAAACGGGGGA; TGTGGTTATGTTCTAAGGCCGTCTATAATGCGAGATGAAGTTTCTTACTTCAGCGCAAATACAAAGGGC; ATTCTACCTGGGGTGTCTCCTCTAGCTCTTCATATCAAGATCATCAGTGGTCAGAATTTCCCAAAGCCC; AAGGGAGCTTGTGCCAAAGGGGATGTCATAGATCCCTATGTTTGTATAGAGATACACGGAATTCCAGCG; GATTGTTCGGAACAAAGAACTAAAACTGTACAGCAAAACAGTGATAATCCTATTTTTGATGAAACTTTT; GAGTTCCAAGTAAACCTACCTGAGCTGGCCATGATCCGTTTTGTTGTTCTGGATGATGACTACATTGGG; GATGAGTTTATAGGGCAATATACGATACCATTTGAATGTTTGCAGCCTGGATATCGGCATGTTCCCCTG; CGTTCTTTTGTGGGTGACATCATGGAGCACGTAACCCTTTTTGTCCACATAGCAATAACTAATCGAAGT; GGAGGAGGAAAGGCACAGAAGCGCAGTCTTTCAGTGAGAATGGGGAAGAAAGTTCGGGAATATACCATG; CTCAGGAATATCGGTCTTAAAACCATTGATGACATCTTTAAAATAGCGGTTCATCCATTACGAGAAGCC; ATAGATATGAGAGAAAATATGCAGAATGCAATCGTGTCTATTAAGGAACTATGTGGACTCCCTCCAATT; GCCAGTCTGAAGCAGTGCCTGTTAACTCTGTCATCTCGGCTCATCACCAGTGACAATACTCCTTCAGTC; TCACTTGTGATGAAAGACAGCTTTCCTTACCTGGAGCCTCTGGGTGCAATTCCAGATGTGCAGAAAAAG; ATGCTGACTGCTTATGATCTGATGATTCAAGAGAGCCGGTTTCTCATAGAAATGGCGGACACAGTCCAG; GAAAAGATTGTACAGTGTCAGAAAGCAGGGATGGAGTTCCATGAAGAACTTCATAATTTGGGGGCAAAA; GAAGGCTTGAAGGGAAGAAAACTCAACAAAGCAACTGAGAGCTTTGCTTGGAACATTACAGTATTGAAG; GGCCAAGGAGATCTGTTGAAGAATGCCAAGAATGAAGCTATAGAAAACATGAAGCAGATCCAGCTGGCA; TGCCTGTCCTGTGGACTGAGTAAAGCCCCCAGCAGCAGTGCTGAGGCCAAGAGCAAGCGCAGCCTGGAA; GCCATAGAGGAGAAGGAAAGTAGTGAGGAGAATGGGAAGCTGTGA; ACGCGTACGCGGCCGCTCGAGCAGAAACTCATCTCAGAAGAGGATCTGGCAGCAAATGATATCCTGGAT; TACAAGGATGACGACGATAAGGTTTAAACGGCCGGC;
• Restriction Sites: SgfI-MluI
• ACCN: NM_006226
• Insert Size: 3288 bp
• OTI Disclaimer: Our molecular clone sequence data has been matched to the reference identifier above as a point of reference. Note that the complete sequence of our molecular clones may differ from the sequence published for this corresponding reference, e.g., by representing an alternative RNA splicing form or single nucleotide polymorphism (SNP).
• OTI Annotation: This TrueClone is provided through our Custom Cloning Process that includes sub-cloning into OriGene's pCMV6 vector and full sequencing to provide a non-variant match to the expected reference without frameshifts, and is delivered as lyophilized plasmid DNA.
• Components: The ORF clone is ion-exchange column purified and shipped in a 2D barcoded Matrix tube containing 10ug of transfection-ready, dried plasmid DNA (reconstitute with 100 ul of water).
• Reconstitution Method: 1. Centrifuge at 5,000xg for 5min.; 2. Carefully open the tube and add 100ul of sterile water to dissolve the DNA.; 3. Close the tube and incubate for 10 minutes at room temperature.; 4. Briefly vortex the tube and then do a quick spin (less than 5000xg) to concentrate the liquid at the bottom.; 5. Store the suspended plasmid at -20°C. The DNA is stable for at least one year from date of shipping when stored at -20°C.
• Note: Plasmids are not sterile. For experiments where strict sterility is required, filtration with 0.22um filter is required.
• Shipping: Ambient

Reference Data

• RefSeq: NM_006226.3
• RefSeq Size: 6608 bp
• RefSeq ORF: 3288 bp
• Locus ID: 5334
• UniProt ID: Q15111
• Cytogenetics: 2q33.1
• Domains: C2, PH, PI-PLC-X, PI-PLC-Y
• Protein Families: Druggable Genome
• MW: 122.7 kDa
• Summary: Involved in an inositol phospholipid-based intracellular signaling cascade. Shows no PLC activity to phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol. Component in the phospho-dependent endocytosis process of GABA A receptor (By similarity). Regulates the turnover of receptors and thus contributes to the maintenance of GABA-mediated synaptic inhibition. Its aberrant expression could contribute to the genesis and progression of lung carcinoma. Acts as an inhibitor of PPP1C.[UniProtKB/Swiss-Prot Function]; Transcript Variant: This variant (2) differs in the 5' UTR and coding sequence compared to variant 1. The resulting isoform (b) is shorter at the N-terminus compared to isoform a.